Losartan ratiopharm Filmtabletten
Recall
|
Medicines
|
02/09/2021
The marketing authorisation holder informed its customers on September 02, 2021 that laboratory analyses of the active ingredient used in the mentioned batches have revealed azido contamination above the acceptable limit.
For this reason, the affected batches are recalled.
| Name of the medicinal product | 1) Losartan ratiopharm 50 mg Filmtabletten 2) Losartan ratiopharm 100 mg Filmtabletten |
|---|---|
| Marketing authorisation number(s) | 1) 1-27321 2) 1-27322 |
| CIP code | 1) 392374 2) 3912380 |
| Marketing authorisation holder | Teva B.V. |
| Batch number(s) | 1) Batch, Expiry Date 0621020, 31.10.2023 0480820, 31.08.2023 0350520, 31.05.2023 0110320, 31.03.2023 0750120, 31.01.2023 0790619, 30.06.2022 2) Batch, Expiry Date 1410820A, 31.08.2023 1410820, 31.08.2023 1090520, 31.05.2023 1580220, 28.02.2023 1590220, 28.02.2023 1311219, 31.12.2022 1031118, 30.11.2021 1590918, 30.09.2021 |
| Classification of the recall | 2 |
| Depth of recall | Pharmacies |
| BASG reference number | INS-640.001-3632 |
Further inquiry note
Page last modified:
02/09/2021